posted on 2023-02-21, 17:53authored byDavid Herzig, Martina Vettoretti, Dominik P. Guensch, Andreas Melmer, Daniel Schürch, Jonathan Roos, Arna M. C. Goerg, Gabija Krutkyte, Luca Cecchini, Andrea Facchinetti, Andreas P Vogt, Lia Bally
<p> </p>
<p><em>Background</em></p>
<p>Continuous glucose monitoring (CGM) may be challenged by extreme conditions during cardiac surgery using hypothermic extracorporeal circulation (ECC).</p>
<p><em>Research Design and Methods</em></p>
<p>We evaluated the Dexcom G6 sensor in 16 subjects undergoing cardiac surgery with hypothermic ECC, of whom 11 received deep hypothermic circulatory arrest (DHCA). Arterial blood glucose, quantified by the Accu-Chek Inform II meter, served as reference. </p>
<p><em>Results </em></p>
<p>Intra-surgery mean absolute relative difference (MARD) of 256 paired CGM/reference values was 23.8%. MARD was 29.1% during ECC (154 pairs) and 41.6% immediately after DHCA (10 pairs), with a negative bias (signed relative difference: -13.7%, -26.6% and -41.6%). During surgery, 86.3% pairs were in Clarke error grid Zones A or B and 41.0% of sensor readings fulfilled the ISO 15197:2013 norm. Post-surgery, MARD was 15.0%.</p>
<p><em>Conclusions</em></p>
<p>Cardiac surgery using hypothermic ECC challenges the accuracy of the Dexcom G6 CGM although recovery appears to occur thereafter. </p>
Funding
Dexcom
Swiss Foundation of Anaesthesiology and Intensive Care